NCT02955043 Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery Status COMPLETED Phase NA
NCT02942173 CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT Status COMPLETED Phase PHASE2/PHASE3
NCT02929498 Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) Status TERMINATED Phase PHASE1/PHASE2
NCT02928419 Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q Status TERMINATED Phase PHASE2
NCT02921815 A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment Status COMPLETED Phase N/A
NCT02921802 A Study of Special Use Results Surveillance of Revlimid 5mg Capsules Status COMPLETED Phase N/A
NCT02916979 Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG Status COMPLETED Phase PHASE1
NCT02912208 Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02909972 Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT02907359 Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs Status COMPLETED Phase PHASE3
NCT02900248 CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice Status TERMINATED Phase N/A
NCT02891551 An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands Status COMPLETED Phase N/A
NCT02867085 Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly Status COMPLETED Phase N/A
NCT02863458 DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US Status WITHDRAWN Phase N/A
NCT02856464 Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy Status UNKNOWN Phase PHASE2
NCT02848001 A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes Status TERMINATED Phase PHASE1
NCT02842229 A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms Status COMPLETED Phase N/A
NCT02841540 A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes Status TERMINATED Phase PHASE1
NCT02835794 A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS) Status WITHDRAWN Phase PHASE1/PHASE2